Sant Pau starts one of the first two studies promoted by the ISCIII to fight against the COVID-19

The trial will study the use of hydroxychloroquine and azithromycin with or without tocilizumab and, among other objectives, whether these drugs reduce in-hospital mortality and the need for mechanical ventilation in the Intensive Care Unit.

More information

This website uses cookies to improve the browsing experience and perform analytical tasks. If you continue browsing, we understand that you agree our cookies policy. More information